BRUKER CORP Earnings Per Share Disclosure
9. Earnings (Loss) Per Share
The following table sets forth the computation of basic and diluted weighted average shares outstanding and associated net income (loss) per common share attributable to Bruker Corporation common shareholders (in millions, except per share amounts):
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Net (loss) income attributable to Bruker Corporation |
|
$ |
(8.6 |
) |
|
$ |
113.1 |
|
|
$ |
427.2 |
|
Dividends on Series A Mandatory Convertible Preferred Stock |
|
|
13.9 |
|
|
|
— |
|
|
|
— |
|
Net (loss) income attributable to Bruker Corporation common shareholders |
|
$ |
(22.5 |
) |
|
$ |
113.1 |
|
|
$ |
427.2 |
|
|
|
|
|
|
|
|
|
|
|
|||
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|||
Weighted average common shares outstanding - basic |
|
|
151.8 |
|
|
|
149.0 |
|
|
|
146.4 |
|
Effect of dilutive securities: |
|
|
|
|
|
|
|
|
|
|||
Stock options, restricted stock units, and employee stock purchase plan |
|
|
— |
|
|
|
0.5 |
|
|
|
0.8 |
|
Series A Mandatory Convertible Preferred Stock |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Weighted average common shares outstanding - diluted |
|
|
151.8 |
|
|
|
149.5 |
|
|
|
147.2 |
|
Net (loss) income per common share attributable to Bruker Corporation |
|
|
|
|
|
|
|
|
|
|||
Basic |
|
$ |
(0.15 |
) |
|
$ |
0.76 |
|
|
$ |
2.92 |
|
Diluted |
|
$ |
(0.15 |
) |
|
$ |
0.76 |
|
|
$ |
2.90 |
|
Due to the Company reporting a net loss for the year ended December 31, 2025, the number of shares used to calculate diluted net loss per common share is the same as the number of shares used to calculate basic net loss per common share because the potentially dilutive shares would have been antidilutive if included in the calculation.
The following common share equivalents have been excluded from the computation of diluted weighted-average shares outstanding, as their effect would have been anti-dilutive (in millions of shares):
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Stock options, restricted stock units, and employee stock purchase plan |
|
|
0.4 |
|
|
|
0.3 |
|
|
|
0.2 |
|
Series A Mandatory Convertible Preferred Stock |
|
|
6.0 |
|
|
|
— |
|
|
|
— |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Feb 28, 2022 | |
| 2020 | Mar 1, 2021 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.